Tag: personalized medicine

Andrea has held senior positions at leading biotechnology companies, including Genzyme (now Sanofi), Oxford Nanopore Technologies, and Illumina, where he led the development of several sequencing products that have transformed genomic analysis worldwide. Andrea Riposati is CEO of Dante Labs, which is developing the first portable, affordable, and accurate whole genome sequencing device. Andrea Riposati…